Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1994 Jun;112(2):352–354. doi: 10.1111/j.1476-5381.1994.tb13077.x

The nonpeptide neurotensin antagonist, SR 48692, used as a tool to reveal putative neurotensin receptor subtypes.

I Dubuc 1, J Costentin 1, J P Terranova 1, M C Barnouin 1, P Soubrié 1, G Le Fur 1, W Rostène 1, P Kitabgi 1
PMCID: PMC1910364  PMID: 8075852

Abstract

The nonpeptide neurotensin (NT) antagonist, SR 48692, was recently shown to inhibit NT binding to the cloned rat and human NT receptor and to antagonize NT effects in a variety of in vitro and in vivo assays. Here, we show that, in contrast to its antagonistic action on NT-induced hypomotility in the rat, SR 48692 failed to antagonize NT-induced hypothermia and analgesia in the mouse and rat. We suggest that these effects might be mediated through a subtype of SR 48692-insensitive NT receptor.

Full text

PDF
352

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Gully D., Canton M., Boigegrain R., Jeanjean F., Molimard J. C., Poncelet M., Gueudet C., Heaulme M., Leyris R., Brouard A. Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor. Proc Natl Acad Sci U S A. 1993 Jan 1;90(1):65–69. doi: 10.1073/pnas.90.1.65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. HALEY T. J., MCCORMICK W. G. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol Chemother. 1957 Mar;12(1):12–15. doi: 10.1111/j.1476-5381.1957.tb01354.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Labbé-Jullié C., Dubuc I., Brouard A., Doulut S., Bourdel E., Pelaprat D., Mazella J., Martinez J., Rostène W., Costentin J. In vivo and in vitro structure-activity studies with peptide and pseudopeptide neurotensin analogs suggest the existence of distinct central neurotensin receptor subtypes. J Pharmacol Exp Ther. 1994 Jan;268(1):328–336. [PubMed] [Google Scholar]
  4. Tanaka K., Masu M., Nakanishi S. Structure and functional expression of the cloned rat neurotensin receptor. Neuron. 1990 Jun;4(6):847–854. doi: 10.1016/0896-6273(90)90137-5. [DOI] [PubMed] [Google Scholar]
  5. Vita N., Laurent P., Lefort S., Chalon P., Dumont X., Kaghad M., Gully D., Le Fur G., Ferrara P., Caput D. Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor. FEBS Lett. 1993 Feb 8;317(1-2):139–142. doi: 10.1016/0014-5793(93)81509-x. [DOI] [PubMed] [Google Scholar]
  6. al-Rodhan N. R., Richelson E., Gilbert J. A., McCormick D. J., Kanba K. S., Pfenning M. A., Nelson A., Larson E. W., Yaksh T. L. Structure-antinociceptive activity of neurotensin and some novel analogues in the periaqueductal gray region of the brainstem. Brain Res. 1991 Aug 23;557(1-2):227–235. doi: 10.1016/0006-8993(91)90139-m. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES